BioXcel Therapeutics, Inc. (BTAI)
2.13
-0.07
(-3.18%)
USD |
NASDAQ |
Dec 09, 16:00
2.13
0.00 (0.00%)
Pre-Market: 08:55
BioXcel Therapeutics Market Cap: 46.58M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xilio Therapeutics, Inc. | 38.44M |
| NovaBay Pharmaceuticals, Inc. | 228.08M |
| Palatin Technologies, Inc. | 25.56M |
| Theriva Biologics, Inc. | 7.524M |
| Oragenics, Inc. | 0.8106M |
Market Cap Related Metrics
| PS Ratio | 21.18 |
| PEG Ratio | -0.0006 |
| Price | 2.13 |
| Earnings Yield | -455.3% |
| PEGY Ratio | -0.0006 |